digestive tract diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age 18-60 years old; 2. ASA grade I-II; 3. Body mass index 25-30 kg/m^2; 4. Voluntarily participate in this study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. People who are allergic to remimazolam or remifentanil; 2. Body mass index > 31 kg/m^2; 3. Obstructive sleep apnea syndrome, acute upper respiratory tract infection, or acute rhinitis; 4. History of tracheostomy or difficult intubation; 5. People with anemia, thrombocytopenia, or abnormal liver or kidney function; 6. Suspected gastrointestinal lesions requiring complex or therapeutic endoscopy; 7. Long-term use of sedatives or painkillers, mental illness, or neurological disorders; 8. Pregnant or breastfeeding.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Camera satisfaction;Side effects; | — |
Countries
China
Contacts
The First People’s Hospital of Huizhou